Embrex Announces Fourth Quarter, Year-End 2005 Financial Results Release and Conference Call

Embrex(R), Inc., The In Ovo Company(R), (Nasdaq:EMBX)
announced Embrex management intends to file its Year-End and Fourth
Quarter 2005 Form 10-K and issue its financial press release on
Wednesday, March 8, 2006. Embrex's management, led by President and
CEO Randall L. Marcuson, will further discuss these financial results
in a conference call on Thursday, March 9, at 11:00 a.m. ET. To join
the conference call, dial [phone] (domestic and Canada), or
[phone] (international), identify Randall Marcuson as the
conference leader, and if asked, provide conference identification
number 5576902.
   This call is being webcast by Thomson/CCBN and can be accessed at
Embrex's web site at www.embrex.com. Click on the Investor Info button
to access the link.
   The webcast is also being distributed over Thomson/CCBN's Investor
Distribution Network to both institutional and individual investors.
Individual investors can listen to the call through Thomson/CCBN's
individual investor center at www.earnings.com or by visiting any of
the investor sites in Thomson/CCBN's Individual Investor Network.
Institutional investors can access the call via Thomson/CCBN's
password-protected event management site, StreetEvents
(www.streetevents.com).
   A telephone replay will be available from approximately 2 p.m. ET
March 9 to midnight ET March 23 by dialing [phone] (domestic
and Canada), or [phone] (international), conference ID 5576902.

   Embrex, Inc., The In Ovo Company(R), is an international
agricultural biotechnology company engaged in the development of
innovative in ovo (in the egg) solutions that meet the needs of
today's global poultry industry.

   Embrex(R) and The In Ovo Company(R) are trademarks of Embrex, Inc.